New
Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
PJP ETF · Invesco Dynamic Pharmaceuticals ETF
The PJP Exchange Traded Fund (ETF) is provided by Invesco. It is built to track an index: Dynamic Pharmaceutical Intellidex Index. The PJP ETF provides physical exposure, so by buying it you actually own parts of all the 29 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update 3/13/2026, 1:30 PM UTC
LIVE
CLOSED
This fund is part ofUS Health Care1M perf.-3.66%
Last price
$101.99
1M perf.
-6.91%
1M flows
+€968K
AuM
€341M
E/R
0.57%
Rating
ESG Consensus®
PJP
$101.99
Performance & flows
Segment for quartile rank
December 15, 2025 → March 13, 2026
Create a free account to view the flows graph
PJP
$102.00
-4.30%
US Health Care
-3.84%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -6.91%  | -4.30%  | +23.05% | +41.97%  | +33.96% | -5.90% | -2.42% | -2.42% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
3/13/2026
$102.00
1D NAV change
-0.81%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
29
Inception date
6/23/2005
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Fund
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
The Invesco Dynamic Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidexâ„ Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
FTXH
1M perf.
-2.89%
E/R
0.6%
IHE
1M perf.
-4.25%
E/R
0.38%
TMED
1M perf.
+0.34%
E/R
0.44%
VHT
1M perf.
-4.77%
E/R
0.09%
FHLC
1M perf.
-3.62%
E/R
0.08%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -4.30% | +23.05% | +41.97% | +33.96% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
94.29%
Ireland
5.71%
Sectors
Health Care
100.00%
Diversification
Total weight of top 15 holdings out of 29
Top 15 holdings
Data as of January 31, 2026
GILEAD SCIENCES
JOHNSON&JOHNSON
MERCK & CO INC
AMGEN-T
PFIZER
LILLY
ABBVIE
ABBOTT LABS
Create a free account to view top holdings
LIQUIDIA CORPORATION
VIATRIS INC
BRISTOL-MYERS SQUIBB
PRESTIGE CONSUMER HEALTHCARE
PERRIGO CO PLC
AMNEAL PHARMACEUTICALS INC
SUPERNUS PHARMACEUTICALS
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about PJP ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
PJP’s has a Final Sustainability Grade of either A+, A, or A-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
90.93% of holdings have positive scoring
9.07% of holdings have negative scoring
7.88%
66.69%
16.36%
6.20%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Trackinsight replication rating:
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
Dynamic Pharmaceutical Intellidex Total Return Index - USD
Index ticker
DZRTR Index
Index dividend policy
NTR
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Invesco
Invesco ID Card
Number of funds
631
Total AuM
€846.61B
Expense ratio range
0.04% - 5.39%
Average expense ratio
0.3562%
Top 5 funds by Invesco
| AuM | ||
|---|---|---|
QQQ | Invesco QQQ ETF | €334.28B |
RSP | Invesco S&P 500® Equal Weight ETF | €73.51B |
QQQM | Invesco NASDAQ 100 ETF | €60.56B |
SPXS | Invesco S&P 500 UCITS ETF | €30.51B |
SGLD | Invesco Physical Gold USD ETC | €28.5B |
Frequently asked questions about PJP
What does Invesco Dynamic Pharmaceuticals ETF, PJP, invest in?
PJP is a Passive ETF. This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities.
Which benchmark or index does PJP replicate?
PJP tracks the Dynamic Pharmaceutical Intellidex Total Return Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of PJP?
PJP carries a total expense ratio (TER) of 0.57%, indicating the annual cost for holding the fund.
When was PJP launched?
PJP was introduced to the market on June 23, 2005. It trades on United States
Who is the ETF issuer of PJP?
Invesco Dynamic Pharmaceuticals ETF, PJP, is provided by Invesco. Learn more about Invesco here.
What is the current assets under management (AUM) of PJP?
PJP oversees €341M in assets as of March 13, 2026.
How has PJP performed lately?
Based on data from March 13, 2026, PJP returned -6.91% over the past month, -4.30% over the last three months and -2.42% year-to-date.
What are the latest inflows or outflows for PJP?
As of March 13, 2026, PJP recorded net flows of +€936K over the last month and +€76M year-to-date.
Does PJP distribute dividends?
PJP follows a distributing dividend policy, meaning it pays out income to investors. As of March 13, 2026, its 12-month trailing yield was 1.00%.
What are the main country or region exposures of PJP?
As of January 31, 2026, PJP has significant geographic allocations in USA and Ireland.
In which sector or theme does PJP invest in?
As of January 31, 2026, PJP focuses largely on Health Care.
How many securities does PJP hold and how diversified is it?
As of January 31, 2026, PJP holds 29 positions in its portfolio, with 63.87% of assets concentrated in its top 15 holdings.
What are the main positions in PJP?
As of January 31, 2026, PJP top three holdings include GILEAD SCIENCES, JOHNSON&JOHNSON and MERCK & CO INC.
What is the base currency of PJP?
The base currency of PJP is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
